CLL Advocates Network Statement

Much of the information about COVID-19 does not address the concerns of people with chronic lymphocytic leukaemia (CLL). With this statement, we wish to fill this gap and provide extra advice for CLL patients.

CLL patients – whether treated or not, young or old – are immune depressed. Treatment can add to the immune deficiency. In view of the foregoing, CLL patients are therefore at high risk of getting COVID-19 and having more severe symptoms than the general population. Therefore, CLL patients should remain especially vigilant.

Armenian

Last updated 10 April 2020 – V2

Click here

Danish

Last updated 16 July 2020 – V3

Click here

Croatian

Last updated 10 April 2020 – V2

Click here

Czech

Last updated 16 July 2020 – V3

Click here

English

Last updated 16 July 2020 – V3

Click here

French

Last updated 16 July 2020 – V3

Click here

German

Last updated 16 July 2020 – V3

Click here

Greek

Last updated 25 March 2020 – V1

Click here

Hungarian

Last updated 25 March 2020 – V1

Click here

Italian

Last updated 10 April 2020 – V2

Click here

Kiswahili

Last updated 16 July 2020 – V3

Click here

Polish

Last updated 25 March 2020 – V1

Click here

Serbian

Last updated 10 April 2020 – V2

Click here

Spanish

Last updated 16 July 2020 – V3

Click here

If you can help translate the statement into your respective language, we would be grateful for support. Please contact us at info@clladvocates.net to ask for the editable files.